1: (ROOT (NP (NP (CD COVI-19) (JJS Newest) (NNP Prevention) (NNP Method)) (: :) (NP (`` `) (NP (NNP Dynamito) (NNP Mitochondria)) ('' `) (NP (NP (NN Article)) (NP (NN courtesy) (PP (IN of) (NP (NP (NP (NP (NP (NNP Kenneth) (NNP Kwok)) (NP (NNP C) (HYPH -) (NNP President))) (PP (IN of) (NP (NNP Asian) (NNP World) (NML (ADJP (NNP Ant) (HYPH -) (NNP Aging)) (CC And) (NML (NNP Wel) (HYPH -) (NNP Being))) (NNP Association)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NNP Founder) (CC and) (NNP CEO)) (PP (IN of) (NP (NNP Global) (NNP Citizen) (NNP Capital))))) (: ;) (PP (IN along) (PP (IN with) (NP (NP (NNP HanChung) (NNP Cheng)) (NP (NP (NNP Chairman)) (PP (IN of) (NP (NNP MitoBioMed)))))))))))) (. .)))
2: (ROOT (S (NP (NP (DT The) (JJ new) (NN coronavirus) (NN disease)) (CD 2019)) (VP (VBZ is) (NP (DT a) (NML (JJ larg) (HYPH -) (NN scale)) (NN outbreak))) (. .)))
3: (ROOT (S (NP (NP (DT The) (NNS symptoms)) (PP (IN of) (NP (CD COVI-19)))) (VP (VBP are) (ADJP (JJ similar) (PP (IN to) (NP (NP (DT the) (NNP SARS) (NN outbreak)) (PP (IN in) (NP (CD 2002)))))) (SBAR (IN because) (S (NP (DT the) (NNS viruses)) (VP (VBP have) (NP (JJ high) (JJ genetic) (NN similarity)))))) (. .)))
4: (ROOT (S (PP (IN During) (NP (DT the) (NN infection))) (, ,) (NP (NNP SAR) (HYPH -) (CD Co-2)) (VP (VP (VBZ represses) (NP (NP (DT the) (NML (NML (NN repair) (NN function)) (CC and) (NML (NN defense) (NN ability)))) (PP (IN of) (NP (NN lung) (NNS macrophages))))) (, ,) (VP (VBZ causes) (NP (NP (JJ severe) (JJ respiratory) (NNS symptoms)) (CC and) (NP (JJ acute) (NN lung) (NN damage)))) (, ,) (CC and) (ADVP (ADVP (RB even)) (ADVP (RB immediately))) (VP (VBZ causes) (NP (NP (NN death)) (PP (IN of) (NP (JJ infected) (NNS patients)))))) (. .)))
5: (ROOT (S (NP (NP (CD COVI-19)) (CC and) (NP (NP (NP (PRP$ its) (NNP First) (NNP Line)) (PP (IN of) (: Defense-) (NP (NNPS Macrophages)))) (NP (NN Lung) (NNS macrophages)))) (VP (VBP are) (NP (NP (JJ important) (JJ immune) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP protect) (PP (IN against) (NP (JJ foreign) (NNS pathogens))) (WHADVP (WRB when)) (S (NP (DT the) (NNS lungs)) (VP (VBP face) (NP (NML (NP (NNS bacteria)) (CC and) (NN virus)) (NN infection)) (PP (IN by) (S (VP (VBG using) (NP (NN phagocytosis)))))))))))) (. .)))
6: (ROOT (S (ADVP (RB Therefore)) (, ,) (NP (NN lung) (NNS macrophages)) (VP (VP (VBP digest) (, ,) (VBP degrade) (CC and) (VBP remove) (NP (DT these) (JJ foreign) (NNS objects))) (CC and) (ADVP (RB further)) (VP (VBP activate) (NP (DT the) (JJ adaptive) (JJ immune) (NN system)) (S (VP (TO to) (VP (VB fight) (PP (IN against) (NP (JJ unknown) (NN infection)))))))) (. .)))
7: (ROOT (S (NP (NN Mitochondria)) (VP (VBP are) (NP (NP (DT a) (JJ major) (NNS contributors)) (PP (IN to) (NP (NN phagocytosis)))) (SBAR (WHADVP (WRB when)) (S (NP (NNS macrophages)) (VP (VBP remove) (NP (DT the) (NN virus) (NN invasion)))))) (. .)))
8: (ROOT (S (NP (NNS Mitochondria)) (VP (VBP provide) (NP (NN energy)) (SBAR (IN for) (S (NP (DT the) (NN macrophage)) (VP (TO to) (VP (VP (VB increase) (NP (PRP$ their) (NN viability))) (CC and) (VP (VB produce) (NP (JJ reactive) (NN oxygen) (NNS species)) (SBAR (S (VP (TO to) (VP (VB kill) (NP (DT the) (NN virus)))))))))))) (. .)))
9: (ROOT (S (SBAR (IN If) (S (NP (NP (DT the) (NNS mitochondria)) (PP (IN in) (NP (NN macrophage)))) (VP (VP (VBP are) (VP (VBN damaged))) (CC or) (VP (MD can) (RB not) (VP (VB function) (ADVP (RB normally))))))) (, ,) (NP (PRP it)) (VP (MD will) (VP (VB be) (ADJP (JJ insufficient) (S (VP (TO to) (VP (VB defend) (PP (IN against) (NP (NP (DT the) (NN invasion)) (PP (IN of) (NP (JJ foreign) (NNS viruses))))))))))) (. .)))
10: (ROOT (S (ADVP (RB Therefore)) (, ,) (NP (PRP it)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN issue)) (PP (IN to) (S (VP (VBG maintaining) (NP (JJ immune) (NN system)) (PP (IN by) (S (VP (VBG keeping) (NP (JJ mitochondrial) (NN function)) (SBAR (WHADVP (WRB when)) (NP (NN virus) (NN infection))))))))))) (. .)))
11: (ROOT (SBARQ (WHNP (WP What)) (SQ (VBZ does) (NP (DT the) (JJS Latest) (NNP Research)) (VP (VB say) (PP (IN about) (NP (NP (NNP Mitochondrial) (NNPS Programs)) (PP (IN for) (NP (NNP Macrophage) (NNP Support))))))) (. ?)))
12: (ROOT (S (ADVP (RB Originally)) (, ,) (NP (JJ severe) (JJ acute) (JJ respiratory) (NN syndrome)) (VP (VBD was) (VP (VBN identified) (PP (IN as) (NP (NP (JJ atypical) (NN pneumonia)) (PP (IN from) (NP (NNP China))))) (PP (IN in) (NP (JJ late) (CD 2002))))) (. .)))
13: (ROOT (S (NP (NP (DT This) (ADJP (RB highly) (JJ contagious)) (JJ respiratory) (NN disease)) (, ,) (PP (IN with) (NP (DT an) (NML (CD 8) (IN to) (CD 15) (NN %)) (NN death) (NN rate))) (, ,)) (ADVP (RB rapidly)) (VP (VBD spread) (PP (PP (IN to) (NP (NP (JJ other) (NNS countries)) (PP (IN within) (NP (NNP Asia))))) (CC and) (PP (IN to) (NP (JJ other) (NNS continents)))) (, ,) (S (VP (VBG causing) (NP (JJ devastating) (ADJP (JJ social) (, ,) (JJ economic) (, ,) (CC and) (JJ medical)) (NN impact)) (ADVP (RB worldwide))))) (. .)))
14: (ROOT (S (NP (NP (DT The) (JJ causative) (NN agent)) (PP (IN of) (NP (NNP SARS)))) (VBZ has) (VBN been) (, ,) (PP (IN after) (NP (JJ intense) (NN research))) (, ,) (VBN identified) (PP (IN as) (NP (DT a) (JJ novel) (NN coronavirus))) (, ,) (VP (VBN designated) (S (NP (NNP SAR) (HYPH -)))) (. CoV.)))
15: (ROOT (S (NP (NP (DT The) (NN transmission)) (PP (IN of) (NP (DT this) (JJ deadly) (NN virus)))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (PP (PP (IN through) (NP (ADJP (NN viru) (HYPH -) (VBN laden)) (NNS droplets))) (CC but) (RB also) (PP (IN via) (NP (CC either) (NML (NML (JJ smal) (HYPH -) (NN particle)) (NN aerosol)) (CC or) (ADJP (NN feca) (HYPH -) (JJ oral)) (NNS routes)))) (, ,) (PP (IN with) (S (NP (DT the) (NNS lungs)) (PP (IN as) (NP (PRP$ its) (JJ main) (JJ pathological) (NN target)))))))))))) (. .)))
16: (ROOT (S (NP (NP (CD I-6)) (CC and) (NP (HYPH I-8))) (VP (VBP are) (NP (NP (JJ critical) (ADJP (NNP SAR) (HYPH -) (NN Co) (HYPH -) (VBN induced)) (NML (CD Cal-3)) (NN cell) (NNS cytokines)) (ADJP (JJ responsible) (, ,) (PP (IN in) (NP (NN part))) (, ,) (PP (IN for) (S (VP (VBG inhibiting) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNP DC))) (S (VP (TO to) (VP (VB prime) (NP (JJ naÃ¯ve) (NNP T) (NNS cells)))))))))))) (. .)))
17: (ROOT (S (NP (NP (NNS Aliquots)) (PP (IN of) (NP (NNP DC)))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (CD -10) (NN medium)) (ADVP (RB alone)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN control) (NNP Ab)) (CC and) (NP (JJ specific) (VBG neutralizing) (NP (NNPS Abs)) (PP (IN against) (NP (CD I-6) (, ,) (CD I-8) (, ,) (CC or) (NP (CD I-10))))))))))) (. .)))
18: (ROOT (S (ADVP (RB Additionally)) (, ,) (NP (PRP they)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (JJ appropriate) (NNS doses)) (PP (IN of) (NP (NP (NN recombinant) (CD I-6)) (, ,) (NP (NN recombinant) (CD I-8)) (, ,) (CC or) (NP (NN recombinant) (CD I-10)))))))) (. .)))
19: (ROOT (S (PP (IN After) (NP (NP (NN cultivation)) (PP (IN for) (NP (CD 3) (NNS days))))) (, ,) (NP (NNP DC)) (VP (VBD were) (VP (VBN harvested) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (JJ naÃ¯ve) (NNP T) (NNS cells))) (PP (IN in) (NP (DT a) (JJ standard) (NNP MLR))))))))) (. .)))
20: (ROOT (S (NP (NP (NML (PP (IN On) (HYPH -) (NP (NN way)))) (NN analysis)) (PP (IN of) (NP (NN variance))) (PP (IN with) (NP (NP (NNP Bonferroni) (POS 's)) (NML (JJ multipl) (HYPH -) (NN comparison)) (NN test)))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ statistical) (NN significance))))))))) (. .)))
21: (ROOT (S (NP (NP (NNS Data)) (VP (VBN presented))) (VP (VBP are) (VP (VBN collected) (PP (IN from) (NP (QP (ADVP (RB at) (JJ minimum)) (CD two)) (JJ independent) (NNS experiments))))) (. .)))
22: (ROOT (S (NP (NNP Dynamito) (NNP Â) (-RRB- ®) (: -) (NP (NP (NNP Improved) (NNP Mitochondrial) (NNP Protection)) (PP (IN of) (NP (NNPS Macrophages) (NNP Mitochondrion) (NNP Applied) (NNP Technology) (NNP C.) (NNP Lt) (. .))))) (VP (VBP have) (VP (VP (VBN discovered) (NP (NP (DT a) (JJ beneficial) (NN ingredient)) (PP (IN for) (NP (JJ mitochondrial) (NN activation))))) (, ,) (VBN screened) (S (VP (VB form) (NP (NP (NNS dozens)) (PP (IN of) (NP (JJ unique) (JJ chinese) (JJ medicinal) (NNS materials)))) (PP (IN in) (NP (NNP Taiwan))))))) (. .)))
23: (ROOT (S (NP (NNP Dynamito) (NNPS MAPEs) (SYM Â) (NNP ®)) (, ,) (VP (VBZ is) (NP (NP (DT a) (JJ mitochondrial) (NN activation) (NN factor)) (, ,) (VP (VBN extracted) (PP (IN from) (NP (DT these) (JJ natural) (NNS herbs))) (PP (IN by) (S (VP (VBG using) (NP (NP (PRP$ our) (JJ patented) (NN technology)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN granted) (NP (NP (JJ many) (NN efficacy) (NNS patents)) (, ,) (VP (VBN approved) (PP (IN from) (NP (NP (NNP Taiwan)) (, ,) (NP (DT the) (NNP USA)) (, ,) (NP (NNP Japan)) (, ,) (NP (NNP China)) (CC and) (NP (JJ many) (JJ other) (NNS countries)))))))))))))))))) (. .)))
24: (ROOT (S (NP (NNS Studies)) (VP (VBP have) (VP (VB demonstrate) (SBAR (IN that) (S (NP (NNP Dynamito) (NNPS MAPEs) (SYM Â) (NNP ®)) (VP (MD can) (VP (VB activate) (CC and) (VB protect) (NP (DT the) (NNS macrophages) (NNS mitochondria)) (, ,) (S (VP (VBG helping) (NP (NNS macrophages)) (S (VP (TO to) (VP (VP (VB establish) (NP (NP (DT the) (JJ first) (NN line)) (PP (IN of) (NP (NN defense)))) (SBAR (SBAR (WHADVP (WRB when)) (S (NP (DT the) (JJ human) (NN body)) (PP (IN against) (NP (JJ foreign) (JJ unknown) (NNS viruses))))) (VP (TO to) (VP (VB avoid) (NP (JJ further) (NN lung) (NN damage)))))) (, ,) (CC and) (VP (VB improve) (NP (NP (NN macrophage) (NN function)) (CONJP (RB as) (RB well) (IN as)) (NP (NN body) (NN protection))))))))))))))) (. .)))
25: (ROOT (S (ADVP (RB Specifically)) (, ,) (NP (NN antioxidant) (NN aim)) (VP (VBZ is) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (JJ free) (NNS radicals)) (PP (IN on) (NP (NP (DT the) (NML (NN body) (NN tissue)) (NN attack)) (VP (VBN caused) (PP (IN by) (NP (NN injury) (CC or) (NN disease))))))))))) (. .)))
26: (ROOT (S (S (NP (NNS Researchers)) (VP (VBD used) (NP (JJ single) (NN plant) (NNS extracts)) (S (VP (TO to) (VP (VB conduct) (NP (NP (NN antioxidant) (NN testing)) (, ,) (CC and) (NP (NP (DT the) (NN compounding)) (PP (IN of) (NP (NN plant) (NNS extracts)))))))))) (: ;) (S (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN to) (NP (DT the) (JJ composite) (NN plant) (NNS extracts)))))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (DT the) (NN antioxidant) (NN capacity)) (VP (VBD increased) (ADVP (RB significantly)))))))) (. .)))
27: (ROOT (S (S (NP (NP (DT The) (JJ cytoplasmic) (NN function)) (PP (IN of) (NP (DT the) (NNS cells)))) (VP (VBD was) (RB not) (VP (VBN destroyed) (PP (IN by) (NP (DT the) (NN hydrogen) (NN peroxide)))))) (, ,) (CC and) (S (SBAR (SBAR (WHADVP (WRB when)) (PP (VBN compared) (PP (IN to) (NP (DT the) (NN control) (NN group))))) (NP (NP (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (FW phyllanthus) (NNP emblica)) (, ,) (NP (JJ red) (NN polyphenol)) (CC and) (NP (JJ green) (NN tea) (NN polyphenol))))) (PP (IN in) (NP (NP (DT the) (NNS compositions)) (PP (IN of) (NP (DT the) (JJ present) (NN invention)))))) (VP (VBD were) (NP (NP (NP (NN 50Î¼/ml)) (, ,) (NP (CD 50Î¼/ml)) (CC and) (NP (CD 5) (NNS Î¼/ml))) (, ,) (ADVP (RB respectively)))))) (, ,) (NP (NP (DT the) (NN base) (NN energy)) (PP (IN of) (NP (JJ cytoskeletal) (NNS cells)))) (VP (VP (VP (VP (VBD increased) (PP (PP (IN by) (NP (CD .13) (NN fold))) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (DT the) (NN composition)))) (VP (VBD was) (NP (NP (NP (NP (NN 50Î¼/ml)) (, ,) (NP (NN 50Î¼/ml))) (NP (CC and) (NP (NP (NP (CD 5) (SYM Î¼g/) (NN ml)) (, ,) (ADVP (RB respectively))) (NP (, ,) (NP (NP (DT the) (NN energy)) (VP (VBN produced) (PP (IN by) (NP (NN ATP))))))))) (VP (VBD increased) (PP (IN by) (NP (NP (DT a) (NN factor)) (PP (PP (IN of) (NP (CD .6) (NNS times))) (: ;) (CC and) (S (NP (DT the) (NN energy)) (VP (VBN used) (S (VP (TO to) (VP (VB cope) (PP (PP (IN with) (NP (DT the) (NN stress))) (VP (VBD was) (VP (VBN increased) (PP (IN by) (NP (CD .7) (ADVP (NNS times)))))))))))))))))))))) (, ,) (S (NP (NP (NN energy)) (PP (IN per) (NP (NP (NN unit)) (PP (IN of) (NP (JJ linear) (NN body)))))) (VP (VBN increased) (PP (IN by) (NP (CD .3) (NNS times)))))) (, ,)) (CC and) (S (NP (NP (DT the) (NN energy) (NN efficiency)) (PP (IN of) (NP (NN oxygen) (NN consumption)))) (VP (VBN increased) (PP (IN by) (NP (CD .4) (NNS times))))))) (. .)))
28: (ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (JJ free) (JJ radical) (NN leakage)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN reduced) (PP (IN by) (NP (CD 4.3) (NN %))))) (. .)))
29: (ROOT (S (S (NP (NNS Experiments)) (ADVP (RB clearly)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ free) (NNS radicals)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN energy) (NN production)) (PP (IN of) (NP (DT the) (NNS cells))))))) (VP (VBP are) (ADVP (RB effectively)) (VP (VBN neutralized) (PP (IN by) (NP (NP (JJ many)) (PP (IN of) (NP (NP (DT the) (JJ free) (NNS radicals)) (PP (IN of) (NP (PRP$ our) (JJ complexed) (NN plant) (NNS extracts))))))))))))) (, ,) (CC and) (S (NP (DT this) (NN action)) (VP (VBZ defends) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (JJ free) (NN attack)) (PP (IN on) (NP (NN body) (NNS tissues)))))))) (. .)))
30: (ROOT (S (NP (NP (DT The) (JJ intracellular) (NN activity)) (PP (IN of) (NP (NNS mitochondria)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VP (VBN enhanced)) (, ,) (CONJP (RB as) (RB well) (IN as)) (S (VP (VBG increasing) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN stem) (NNS cells)))))))) (. .)))
31: (ROOT (FRAG (IN About) (NP (NP (NNP Global) (NNP Citizen) (NNP Capital)) (NP (DT A) (NNP Hybrid) (NML (NML (NNP Fo) (HYPH -) (NNP Profit)) (CC and) (NNP Nonprofit)) (NNP Impact) (NNP Venture))) (, ,) (PP (PP (VBG including) (: :) (NNP Fo) (HYPH -) (: Profit-) (NP (NNP Global) (NNP Citizen) (NNP Capital)) (CC and) (NML (NNP No) (HYPH -) (HYPH Profit-) (NML (NNP Better) (NNP Together))) (NNP Foundation) (CC and) (NP (NP (NNP Asia) (NNP World) (NML (NML (NNP Ant) (HYPH -) (NNP Aging)) (CC and) (NML (NNP Wel) (HYPH -) (NNP Being))) (NNP Association)) (PP (IN Since) (NP (NN inception))))) (, ,) (NP (NP (NNP GCC)) (PP (IN as) (NP (DT an) (NN impact) (NN investment) (NN fund)))) (VP (VBZ has) (VP (VBN focused) (PP (IN on) (NP (NP (CD one) (JJ core) (NN mission)) (: :) (S (VP (VP (TO to) (VP (VB improve) (NP (NP (NNP on#QualityofLife)) (PP (IN of) (NP (DT all)))))) (CC and) (VP (TO to) (NP (NNP bring#AffordablePreventiveHealthcare)) (PP (IN to) (NP (DT all))) (, ,) (PP (IN in) (NP (NP (NN adherence)) (PP (IN with) (NP (NP (NNP United) (NNPS Nations)) (CC and) (NP (PRP$ its) (NML (NNP Sustainable) (NNP Development)) (NNPS Goals)))))))))))))) (. .)))
32: (ROOT (S (PP (IN As) (NP (NP (DT the) (NN venture) (NN arm)) (PP (IN of) (NP (NP (DT an) (ADJP (NNP Asi) (HYPH -) (VBN based)) (NML (JJ mult) (HYPH -) (NN family)) (NN office) (NN investment) (NN fund)) (VP (VBN associated) (PP (IN with) (NP (NP (NNP SHK) (NNP C.)) (, ,) (NP (NNP China) (NNP Orient) (NNP Group)) (CC and) (NP (JJ other) (JJ affluent) (JJ Asian) (NNS families))))))))) (, ,) (NP (NNP GCC)) (VP (VBZ fosters) (NP (NNS companies)) (PP (IN through) (NP (NP (DT a) (NML (CD 360) (NN degree)) (NN approach)) (PP (IN in) (NP (NP (NML (NN business) (NN model)) (NN formulation)) (, ,) (NP (NN network) (NN building)) (, ,) (NP (NN business) (NN generation)) (, ,) (NP (NN capital) (NN funding)) (CC and) (NP (ADVP (RBS most) (RB importantly)) (, ,) (NP (NN leadership) (NN mentoring)))))))) (. .)))
33: (ROOT (PP (IN About) (NP (NP (NNP MitoBioMed) (NNP Mitochondrion) (NNP Application)) (NP (NP (NNP Biomedicine)) (PP (IN In)))) (. ..)))
34: (ROOT (S (VP (VBZ is) (NP (NP (DT a) (JJ global) (VBG emerging) (NML (JJ regenerative) (NN medicine)) (NN leader)) (VP (VBN based) (PP (IN on) (NP (NML (JJ mitochondrial) (JJ medical) (NN technology)) (NN application) (NNS solutions)))))) (. .)))
35: (ROOT (S (NP (NNP MitoBioMed)) (VP (VP (VBZ holds) (NP (QP (JJR more) (IN than) (CD 17)) (JJ international) (NNS patents))) (, ,) (VP (VBZ develops) (NP (NML (CC &) (NNP D)) (CC and) (NML (NML (NN engineering) (NN application)) (NN technology)) (NNS platforms))) (, ,) (CC and) (VP (VBZ operates) (NP (NNS bases)) (PP (IN in) (NP (NP (NNP Taiwan)) (, ,) (NP (NNP Beijing)) (, ,) (NP (NNP Shenzhen)) (, ,) (NP (NNP Hong) (NNP Kong)) (CC and) (NP (JJ other) (NNS places)))))) (. .)))
36: (ROOT (S (PP (IN With) (NP (NP (DT the) (NN advent)) (PP (IN of) (NP (DT an) (VBG aging) (NN society))))) (, ,) (NP (NP (JJ many) (NNS studies)) (PP (IN in) (NP (DT the) (JJ past) (CD ten) (NNS years)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NNS mitochondria)) (VP (VBP are) (ADJP (RB closely) (VBN related) (PP (IN to) (NP (NP (NN aging)) (CC and) (NP (JJ degenerative) (NNS diseases)))))))))) (. .)))
37: (ROOT (S (NP (DT This)) (VP (VBZ is) (SBAR (IN because) (S (SBAR (WHADVP (WRB when)) (S (NP (JJ mitochondrial) (NN function)) (VP (VBZ is) (ADJP (JJ abnormal))))) (, ,) (NP (PRP it)) (VP (MD will) (VP (VP (VB trigger) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (NN energy) (NN supply)) (CC and) (NP (JJ oxidative) (NN stress)))))) (, ,) (CC and) (ADVP (RB even)) (VP (VB induce) (NP (NNS cells)) (S (VP (TO to) (VP (VB enter) (NP (NP (NP (NN apoptosis)) (CC or) (NP (NN autophagy))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD will) (VP (VB cause) (NP (NN disease)))))))))))))))) (. .)))
38: (ROOT (S (NP (NNP MitoBioMed)) (VP (VBZ is) (NP (NP (DT a) (JJ corporate) (NN advocate)) (PP (IN for) (NP (NP (DT the) (NNP United) (NNPS Nations)) (CC and) (NP (PRP$ its) (NML (NNP Sustainability) (NNP Development)) (NNPS Goals)))))) (. .)))
